Recently, the Department of Emergency of Ngari Prefecture People’s Hospital admitted a 54-year-old male patient of Zang ethnicity. The patient had spontaneous rupture and hemorrhage of primary liver cancer, with more than 1,000 mL of intra-abdominal blood accumulation, and was a rare Rh-negative “panda blood” type, leaving him in a ...
On December 6, 2025, Professor Yao Yu from the Department of Medical Oncology of the First Affiliated Hospital (FAH) of Xi’an Jiaotong University (XJTU), as a co-first author, published important findings in the international top-tier medical journal The Lancet Oncology (IF = 35.9), in a paper entitled “Vebreltinib in MET amplificati...
On December 8, 2025, an international expert panel comprising Professor Jeyaraj Pandian, President of the World Stroke Organization (WSO), and Professor Li Shen from Beijing Shijitan Hospital, Capital Medical University, visited the First Affiliated Hospital (FAH) of Xi’an Jiaotong University (XJTU) to carry out an on-site evaluation ...
On the morning of November 26, 2025, an international multicenter clinical trial project led by Professor Xue Wujun of the Department of Kidney Transplantation of the First Affiliated Hospital (FAH) of Xi’an Jiaotong University (XJTU) was officially launched. Professor Xue Wujun, together with the research team, representatives of the...
Recently, Cell Press, publisher of the world-leading international academic journal Cell, announced the 2024 “Most Popular China Paper Award”. The team of Yuan Zuyi, Wu Yue and Li Ting from the First Affiliated Hospital (FAH) of Xi’an Jiaotong University (XJTU) received this honor for their paper entitled “A gut microbiota-bile aci...
